- Home
- ACAD vs PSNY Comparison
ACAD vs PSNY Comparison
Compare ACAD & PSNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACAD
- PSNY
- Stock Information
- Founded
- ACAD 1993
- PSNY 2017
- Country
- ACAD United States
- PSNY Sweden
- Employees
- ACAD N/A
- PSNY N/A
- Industry
- ACAD Biotechnology: Pharmaceutical Preparations
- PSNY Auto Manufacturing
- Sector
- ACAD Health Care
- PSNY Consumer Discretionary
- Exchange
- ACAD Nasdaq
- PSNY Nasdaq
- Market Cap
- ACAD 2.8B
- PSNY 2.8B
- IPO Year
- ACAD 2004
- PSNY N/A
- Fundamental
- Price
- ACAD $17.57
- PSNY $1.09
- Analyst Decision
- ACAD Buy
- PSNY Hold
- Analyst Count
- ACAD 19
- PSNY 8
- Target Price
- ACAD $26.17
- PSNY $1.39
- AVG Volume (30 Days)
- ACAD 4.3M
- PSNY 6.1M
- Earning Date
- ACAD 02-25-2025
- PSNY 02-10-2025
- Dividend Yield
- ACAD N/A
- PSNY N/A
- EPS Growth
- ACAD N/A
- PSNY N/A
- EPS
- ACAD 0.78
- PSNY N/A
- Revenue
- ACAD $929,236,000.00
- PSNY $2,046,740,000.00
- Revenue This Year
- ACAD $36.78
- PSNY $33.53
- Revenue Next Year
- ACAD $8.19
- PSNY $105.29
- P/E Ratio
- ACAD $22.63
- PSNY N/A
- Revenue Growth
- ACAD 47.06
- PSNY N/A
- 52 Week Low
- ACAD $14.15
- PSNY $0.61
- 52 Week High
- ACAD $29.29
- PSNY $2.33
- Technical
- Relative Strength Index (RSI)
- ACAD 52.06
- PSNY 48.54
- Support Level
- ACAD $16.61
- PSNY $1.03
- Resistance Level
- ACAD $18.23
- PSNY $1.24
- Average True Range (ATR)
- ACAD 0.74
- PSNY 0.10
- MACD
- ACAD -0.05
- PSNY 0.00
- Stochastic Oscillator
- ACAD 36.59
- PSNY 29.17
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
About PSNY Polestar Automotive Holding UK PLC ADS
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market-leading standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from USA.